Tags » Pharmaceuticals

J&J buys Alios BioPharma to gain access to infant medicine

Johnson & Johnson has agreed to buy Alios BioPharma for $1.75 billion in an all-cash deal, the company announced Tuesday.

The privately-held biopharmaceutical company is focused on developing medicines to fight viral diseases, including a valuable treatment for infants with the respiratory syncytial virus, which causes infections of the lungs and respiratory tract. 150 more words

Finance

Global Calcium Pvt Ltd - Pharmaceuticals - Planning - Tamil Nadu

Company : Global Calcium Pvt Ltd
Sector : Pharmaceuticals
SubSector : Pharmaceuticals
Products and Capacity : Active Pharmaceutical Ingredients (60 TPA)
Location : Hosur, Dharmapuri… 101 more words

Tamil Nadu

There is nothing classic about it. CLASSIC-NMR

I thought I would thank everyone for┬átaking a look at my┬álast post, “You could add a little bit of soap to that”. My site is picking up quite a few visits since I started posting again. 555 more words

Pharmaceuticals

Gertrude Elion


Gertrude Elion was a biochemist and pharmacologist who formulated many medicines for common and serious illnesses. Gertrude studied chemistry in school, but difficulties finding a research position eventually caused her to give up pursing her doctorate. 282 more words

Science

Withdrawal of drug price cap guidelines to be on prospective basis

The government’s decision to withdraw the drug pricing authority’s powers to fix the prices of non-essential medicines will be on a prospective basis, and will not affect price caps imposed in July on 108 drugs.The official in the drug pricing authority declined to be named due to the sensitivity of the matter.

Source

Pharmaceuticals

Government plans survey to test, steps to tighten drug quality

A largest nationwide survey with a sample size of over 40,000 drugs is going to be conducted to estimate the extent of sub-standard and spurious drugs in the country alongside a series of measures to plug the gaps on quality of drugs in circulation.

Source

Pharmaceuticals

Peter Koures: About CardioPredict

Peter Koures began working at Interpace Diagnostics, LLC in 2013, the year that it was formed by PDI Inc., a commercialization leader with more than twenty-five years of experience in the industry. 257 more words

Peter Koures